HRP20010335B1 - Novel erythromycin derivatives, preparation method and use as medicines - Google Patents

Novel erythromycin derivatives, preparation method and use as medicines

Info

Publication number
HRP20010335B1
HRP20010335B1 HR990077A HRP20010335A HRP20010335B1 HR P20010335 B1 HRP20010335 B1 HR P20010335B1 HR 990077 A HR990077 A HR 990077A HR P20010335 A HRP20010335 A HR P20010335A HR P20010335 B1 HRP20010335 B1 HR P20010335B1
Authority
HR
Croatia
Prior art keywords
medicines
preparation
erythromycin derivatives
novel erythromycin
novel
Prior art date
Application number
HR990077A
Other languages
English (en)
Inventor
Constantin Agouridas
Alexis Denis
Claude Fromentin
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HRP20010335A2 publication Critical patent/HRP20010335A2/hr
Publication of HRP20010335B1 publication Critical patent/HRP20010335B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR990077A 1998-11-10 2001-05-10 Novel erythromycin derivatives, preparation method and use as medicines HRP20010335B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814145A FR2785612A1 (fr) 1998-11-10 1998-11-10 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1999/002718 WO2000027857A2 (fr) 1998-11-10 1999-11-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
HRP20010335A2 HRP20010335A2 (en) 2002-06-30
HRP20010335B1 true HRP20010335B1 (en) 2003-08-31

Family

ID=9532584

Family Applications (1)

Application Number Title Priority Date Filing Date
HR990077A HRP20010335B1 (en) 1998-11-10 2001-05-10 Novel erythromycin derivatives, preparation method and use as medicines

Country Status (28)

Country Link
US (2) US6455505B2 (ja)
EP (1) EP1016669B1 (ja)
JP (1) JP4698783B2 (ja)
KR (1) KR100567695B1 (ja)
CN (2) CN100351238C (ja)
AR (1) AR025814A1 (ja)
AT (1) ATE232879T1 (ja)
AU (1) AU766138B2 (ja)
BR (1) BR9915236A (ja)
CA (1) CA2350651C (ja)
CZ (1) CZ20011622A3 (ja)
DE (1) DE69905447T2 (ja)
DK (1) DK1016669T3 (ja)
EA (1) EA200100533A1 (ja)
ES (1) ES2189365T3 (ja)
FR (1) FR2785612A1 (ja)
HR (1) HRP20010335B1 (ja)
HU (1) HUP0104035A3 (ja)
IL (2) IL142996A0 (ja)
NO (1) NO20012272L (ja)
NZ (1) NZ511609A (ja)
PL (1) PL348098A1 (ja)
PT (1) PT1016669E (ja)
SI (1) SI20640A (ja)
TR (1) TR200101286T2 (ja)
TW (1) TWI237027B (ja)
WO (1) WO2000027857A2 (ja)
ZA (1) ZA200103801B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA11753A (en) * 1999-01-27 2005-07-19 Pfizer Prod Inc Ketolide antibiotics.
AP2001002302A0 (en) 1999-05-24 2001-10-25 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
DK1167376T3 (da) 2000-06-30 2004-10-25 Pfizer Prod Inc Makrolidantibiotika
JP2004017020A (ja) * 2002-06-20 2004-01-22 Sony Corp コーティング方法および被コーティング粒子
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ，インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
EP2968384A4 (en) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN111825733A (zh) 2013-04-04 2020-10-27 哈佛大学的校长及成员们 大环内酯及其制备和使用方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
CN107530365A (zh) 2015-03-25 2018-01-02 哈佛大学的校长及成员们 具有修饰的脱氧糖胺糖的大环内酯及其用途
EP3190122A1 (en) * 2016-01-08 2017-07-12 LEK Pharmaceuticals d.d. A novel synthetic pathway towards solithromycin and purification thereof
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
FR2669337B1 (fr) * 1990-11-21 1995-03-24 Roussel Uclaf Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PL188173B1 (pl) * 1996-09-04 2004-12-31 Abbott Lab Pochodne erytromycyny, sposób wytwarzania pochodnych erytromycyny i środek o działaniu przeciwbakteryjnym
US6165986A (en) * 1997-03-10 2000-12-26 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives

Also Published As

Publication number Publication date
KR100567695B1 (ko) 2006-04-05
CN100351238C (zh) 2007-11-28
ES2189365T3 (es) 2003-07-01
TWI237027B (en) 2005-08-01
EA200100533A1 (ru) 2001-10-22
CN1814592A (zh) 2006-08-09
PL348098A1 (en) 2002-05-06
WO2000027857A3 (fr) 2000-08-17
ATE232879T1 (de) 2003-03-15
SI20640A (sl) 2002-02-28
CA2350651A1 (fr) 2000-05-18
DE69905447D1 (de) 2003-03-27
FR2785612A1 (fr) 2000-05-12
US6455505B2 (en) 2002-09-24
BR9915236A (pt) 2002-01-08
JP4698783B2 (ja) 2011-06-08
NZ511609A (en) 2003-07-25
US20020013281A1 (en) 2002-01-31
KR20010080970A (ko) 2001-08-25
CA2350651C (fr) 2010-07-20
US20020028781A1 (en) 2002-03-07
HUP0104035A3 (en) 2003-12-29
AU1052600A (en) 2000-05-29
NO20012272D0 (no) 2001-05-09
CN1333782A (zh) 2002-01-30
AU766138B2 (en) 2003-10-09
HUP0104035A2 (hu) 2002-02-28
TR200101286T2 (tr) 2001-09-21
DE69905447T2 (de) 2003-07-24
HRP20010335A2 (en) 2002-06-30
IL142996A0 (en) 2002-04-21
DK1016669T3 (da) 2003-05-26
IL142996A (en) 2006-12-10
ZA200103801B (en) 2002-05-10
EP1016669B1 (fr) 2003-02-19
EP1016669A1 (fr) 2000-07-05
NO20012272L (no) 2001-07-10
AR025814A1 (es) 2002-12-18
CZ20011622A3 (cs) 2001-09-12
JP2000143689A (ja) 2000-05-26
CN1240708C (zh) 2006-02-08
PT1016669E (pt) 2003-07-31
US6407257B1 (en) 2002-06-18
WO2000027857A2 (fr) 2000-05-18

Similar Documents

Publication Publication Date Title
HU9603038D0 (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HU9503505D0 (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
PL348098A1 (en) Novel erythromycin derivatives, preparation method and use as medicines
PL346530A1 (en) Azetidine derivatives, preparation and medicines containing them
HUP9902576A3 (en) Novel erythromycin derivatives, method for preparing them, and use thereof as drugs
IL141769A0 (en) Azetidine derivatives, preparation and medicines containing them
HUP0002252A3 (en) 9-oxime erythromycin derivatives, process for preparing them and pharmaceutical compositions containing them
PL343512A1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
ZA997176B (en) Derivatives of erythromycin, their preparation process and their use as medicaments.
ZA200109602B (en) Purine derivatives, preparation method and pharmaceutical compositions containing same.
HUP0103316A3 (en) 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
HUP0104620A3 (en) 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them
HUP0104819A3 (en) Chroman derivatives, their use intermediate and process for their preparation
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
HUP0001245A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
HUP0001180A3 (en) Novel erythromycin derivatives, method for preparing them and their use as medicine
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
HUP0001452A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
HUP0102518A3 (en) 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them
HUP0103997A3 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
IL125372A0 (en) Erythromycin derivatives and methods for the preparation thereof
HUP0102618A3 (en) Methyl-biphenyl derivatives, their preparation method and use as intermediate

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20031028

Year of fee payment: 5

PBON Lapse due to non-payment of renewal fee

Effective date: 20041110